Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2980-2987

  Kurz, Sabine ^a   Steffens, Hans Peter ^a   Mayer, Anna ^a   Harris, James R ^a   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CYTOMEGALOVIRUS; DATA ANALYSIS; DNA DETERMINATION; GENOME; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; QUANTITATIVE DIAGNOSIS; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS LATENCY;

EID: 0030945467     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2980-2987.1997     Document Type: Article

References (40)

1. Badley, J. E., G. A. Bishop, T. St. John, and J. A. Frelinger. 1988. A simple, rapid method for the purification of poly A + RNA. BioTechniques 6:114-116.
2. Balthesen, M., L. Dreher, P. Lucin, and M. J. Reddehase. 1994. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J. Gen. Virol. 75:2329-2336.
3. Balthesen, M., M. Messerle, and M. J. Reddehase. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:5360-5366.
4. Balthesen, M., M. Susa, P. Lucin, and M. J. Reddehase. 1994. Cytomegalovirus DNA detected in blood leucocytes after resolution of productive infection does not originate from latently infected hematopoietic stem cells in the bone marrow. Croat. Med. J. 35:19-25.
5. Chong, K. T., and C. A. Mims. 1981. Murine cytomegalovirus particle types in relation to sources of virus and pathogenicity. J. Gen. Virol. 57:415-419.
6. Ebeling, A., G. M. Keil, E. Knust, and U. H. Koszinowski. 1983. Molecular cloning and physical mapping of murine cytomegalovirus DNA. J. Virol. 47:421-433.
7. Fazekas de St. Groth, S. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods 49:R11-R23.
8. Grundy, J. E., M. Super, S. Lui, P. Sweny, and P. D. Griffiths. 1987. The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney. Transplant. Proc. 19:2126-2128.
9. Harris, J. R. 1997. Negative staining and cryoelectron microscopy: the thin film techniques. Bios Scientific Publishers, Oxford, England.
10. Harris, J. R., and R. W. Horne. 1991. Negative staining, p. 203-208. In J. R. Harris (ed.), Electron microscopy in biology. IRL Press, Oxford, England.
11. Henry, S. C., and J. D. Hamilton. 1993. Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice. J. Infect. Dis. 167:950-954.
12. Ho, M. 1991. Observations from transplantation contributing to the understanding of pathogenesis of CMV infection. Transplant. Proc. 23(Suppl. 3):104-109.
13. Hodgkin, P. D., A. A. Scalzo, N. Swaminathan, P. Price, and G. R. Shellam. 1988. Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. J. Virol. Methods 22:215-230.
14. Hudson, J. B., V. Misra, and T. R. Mosmann. 1976. Cytomegalovirus infectivity: analysis of the phenomenon of centrifugal enhancement of infectivity. Virology 72:235-243.
15. Jonjic, S., W. Mutter, F. Weiland, M. J. Reddehase, and U. H. Koszinowski. 1989. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J. Exp. Med. 169:1199-1212.
16. Jordan, M. C. 1983. Latent infection and the elusive cytomegalovirus. Rev. Infect. Dis. 5:205-215.
17. Keil, G. M., A. Ebeling Keil, and U. H. Koszinowski. 1987. Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J. Virol. 61:1901-1908.
18. Klotman, M. E., S. C. Henry, R. C. Greene, P. C. Brazy, P. E. Klotman, and J. D. Hamilton. 1990. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J. Infect. Dis. 161:220-225.
19. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91:11879-11883.
20. Kondo, K., and E. S. Mocarski. 1995. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand. J. Infect. Dis. Suppl. 99:63-67.
21. Konecki, D. S., J. Breimand, J. C. Fuscoe, C. T. Caskey, and A. C. Chinault. 1982. Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res. 10:6763-6775.
22. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U. H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol. 75:101-110.
23. Maciejewski, J. P., E. E. Bruening, R. E. Donahue, E. S. Mocarski, N. S. Young, and S. C. St. Jeor. 1992. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170-178.
24. Mercer, J. A., J. R. Marks, and D. H. Spector. 1983. Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith strain). Virology 129:94-106.
25. Mercer, J. A., C. A. Wiley, and D. H. Spector. 1988. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62:987-997.
26. Messerle, M., B. Bühler, G. M. Keil, and U. H. Koszinowski. 1992. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J. Virol. 66:27-36.
27. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
28. Mocarski, E. S. 1996. Cytomegaloviruses and their replication, p. 2447-2492. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
29. Mocarski, E. S., Jr., G. B. Abenes, W. C. Manning, L. C. Sambucetti, and J. M. Cherrington. 1990. Molecular genetic analysis of cytomegalovirus gene regulation in growth, persistence, and latency. Curr. Top. Microbiol. Immunol. 154:47-74.
30. Mutter, W., M. J. Reddehase, F. W. Busch, H. J. Bühring, and U. H. Koszinowski. 1988. Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J. Exp. Med. 167:1645-1658.
31. Pollock, J. L., and H. W. Virgin IV. 1995. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J. Virol. 69:1762-1768.
32. Pomeroy, C., P. J. Hilleren, and M. C. Jordan. 1991. Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J. Virol. 65:3330-3334.
33. Reddehase, M. J., M. Balthesen, M. Rapp, S. Jonjic, I. Pavic, and U. H. Koszinowski. 1994. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:185-193.
34. Reddehase, M. J., F. Weiland, K. Münch, S. Jonjic, A. Lüske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264-273.
35. Roizman, B., and A. E. Sears. 1987. An inquiry into the mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol. 41:543-571.
36. Shakhov, A. N., and S. A. Nedospasov. 1987. Molecular cloning of genes coding for tumor necrosis factor. Complete nucleotide sequence of the genome copy of TNF-alpha in mice. Bioorg. Khim. 13:701-705.
37. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:7313-7316.
38. Weiland, F., G. M. Keil, M. J. Reddehase, and U. H. Koszinowski. 1986. Studies on the morphogenesis of murine cytomegalovirus. Intervirology 26: 192-201.
39. Yu, Y., S. C. Henry, F. Xu, and J. D. Hamilton. 1995. Expression of a murine cytomegalovirus early-late protein in "latently" infected mice. J. Infect. Dis. 172:371-379.
40. Yuhasz, S. A., V. B. Dissette, M. L. Cook, and J. G. Stevens. 1994. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology 202:272-280.